Isolation of estrogen-responsive genes with a CpG island library
about
Cloning the cDNA for a new human zinc finger protein defines a group of closely related Krüppel-like transcription factorsA genomewide linkage-disequilibrium scan localizes the Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency to 2p16Estrogen, mitochondria, and growth of cancer and non-cancer cellsAutocrine gastrins in colon cancer cells Up-regulate cytochrome c oxidase Vb and down-regulate efflux of cytochrome c and activation of caspase-3Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptorsPrecursor peptide progastrin(1-80) reduces apoptosis of intestinal epithelial cells and upregulates cytochrome c oxidase Vb levels and synthesis of ATPUnderdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha.Tumor-associated, estrogen receptor-related antigen EBAG9: linking intracellular vesicle trafficking, immune homeostasis, and malignancy.Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.Hormonal regulation of cardiac KCNE2 gene expression.Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens.EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer.Estrogen receptor interaction with estrogen response elementsDiversity in the mechanisms of gene regulation by estrogen receptors.Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.The respiratory chain supercomplex organization is independent of COX7a2l isoforms.Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technologySignificance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas.Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.Nuclear respiratory factor 1 controls myocyte enhancer factor 2A transcription to provide a mechanism for coordinate expression of respiratory chain subunitsBioactivation of Selective Estrogen Receptor Modulators (SERMs)In silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules.EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.Differential gene regulation by the SRC family of coactivators.Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.COX7AR is a Stress-inducible Mitochondrial COX Subunit that Promotes Breast Cancer Malignancy.The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells.Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target.Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?Involvement of estrogen receptors in prostatic diseases.Functional analysis of p53 binding under differential stresses.EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma.EBAG9 is a tumor-promoting and prognostic factor for bladder cancer.Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer.Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines.Deficiency of COX7RP, a mitochondrial supercomplex assembly promoting factor, lowers blood glucose level in mice.EBAG9 modulates host immune defense against tumor formation and metastasis by regulating cytotoxic activity of T lymphocytesRegulation of mouse Slo gene expression: multiple promoters, transcription start sites, and genomic action of estrogen.
P2860
Q22003965-7F6277A4-6E62-463F-BFAB-A037C8F2E69FQ24535681-C7C27DCF-63D1-4452-907C-655F5C79BAB0Q24799692-887D0A70-F268-4FA1-B115-1F0DEF88393BQ28142107-8317C3F2-4259-4E35-9FEF-C69BC7F69394Q28240530-398A704B-76C0-4D1A-AA2A-8AA7CC39732EQ28571033-81B34C03-3291-480A-A888-59CF41A1D055Q30789721-660152C2-D34F-4DE2-8960-246B1ED2AA4DQ33655825-C8F77FE8-02F4-478A-A346-F093BF960D3FQ33658348-66E59B35-02D2-40B2-8F33-D5DF366AA890Q33945450-DCF25AA4-D832-45FF-BC71-C0769D918969Q34045766-8AFDCA1C-FF55-474E-AB86-AA0229E6EAD9Q34188015-547C1C70-30B7-4826-86E1-6F65D7B2995DQ34211979-3AA72844-4E43-4CF4-B7CC-8F8A0A026F3CQ34307898-C14251E1-9DE9-49BF-8FFC-A233269D6867Q34561503-2FC4C9F8-2315-4068-94E8-CB902ACBBCC2Q34652138-CACACA97-1EEF-4680-97AE-D4038CA548EDQ34664166-EBEED2C4-5F5A-4ADE-B218-13ACDBD1879AQ35593300-AEE53707-04DA-4396-8652-224728B010FEQ36063718-122829A4-3AA3-4ACA-8894-2AC2261E2376Q36209749-F54E0F65-0D0B-41B7-9F55-DC68A4FCFFBEQ36447455-4DF95D4F-1801-4301-AF10-EC9DDFCCF07AQ36585576-198F3AF0-697E-4E1C-83C9-261B6B98746CQ36595120-407B31B0-8E5A-44F1-AC10-DDCA686EE73DQ36602448-2977E80E-F388-4D6D-9D41-807C02ED9950Q36623198-1BB0542F-0EC9-435B-8EE4-7B1E3C2FA3A6Q36661242-6CB4B0DE-1B7D-4351-995E-71AD4BEBA3D1Q36694163-2B1E6165-42E3-49E6-90E8-D04019A918E2Q37195626-873B722E-240C-445F-B648-45DF52901848Q37286671-7EDA16B2-CBC6-42DA-9472-8B62EFE87877Q37490217-414839D0-3714-4BFC-9BF2-8609650DAE34Q37854068-8185EF24-0EFD-4C11-8F16-F50EDAC71CD4Q37989170-5E63980A-3A27-42D7-B8E3-C5C33018065CQ38411497-7EC24497-5DC8-4EF1-8414-6E9A901821EDQ39850984-3B5A19DC-3FA0-4E16-B0D8-813D255ED92DQ39912689-A7EBA096-27B3-47C9-ABB6-44134C29C014Q40082126-37CF84D4-7C6C-482F-B607-C3A3D3B6CC1CQ40176914-7E2A19B6-1736-483C-90DF-939DFA42FB13Q41311783-33146F44-097E-460A-B1CC-1900EF02BCE8Q42536212-F8BA4EE3-018B-414E-AF84-1BA27540857FQ42826464-C1C55C0E-1B7A-45C7-96D4-8DBFB7C4D674
P2860
Isolation of estrogen-responsive genes with a CpG island library
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Isolation of estrogen-responsive genes with a CpG island library
@ast
Isolation of estrogen-responsive genes with a CpG island library
@en
Isolation of estrogen-responsive genes with a CpG island library
@en-gb
Isolation of estrogen-responsive genes with a CpG island library
@nl
type
label
Isolation of estrogen-responsive genes with a CpG island library
@ast
Isolation of estrogen-responsive genes with a CpG island library
@en
Isolation of estrogen-responsive genes with a CpG island library
@en-gb
Isolation of estrogen-responsive genes with a CpG island library
@nl
prefLabel
Isolation of estrogen-responsive genes with a CpG island library
@ast
Isolation of estrogen-responsive genes with a CpG island library
@en
Isolation of estrogen-responsive genes with a CpG island library
@en-gb
Isolation of estrogen-responsive genes with a CpG island library
@nl
P2093
P2860
P3181
P356
P1476
Isolation of estrogen-responsive genes with a CpG island library
@en
P2093
P2860
P3181
P356
10.1128/MCB.18.1.442
P407
P577
1998-01-01T00:00:00Z